Article
Assessment of glutamate transporter GLAST (EAAT1)-deficient mice for phenotypes relevant to the negative and executive/cognitive symptoms of schizophrenia.
Neuropsychopharmacology : official publication of the American College of Neuropsychopharmacology - 1 May 2009
Karlsson Rose-Marie, Tanaka Kohichi, Saksida Lisa M, Bussey Timothy J, Heilig Markus, Holmes Andrew
Abstract excerpt
Glutamatergic dysfunction is increasingly implicated in the pathophysiology of schizophrenia. Current models postulate that dysfunction of glutamate and its receptors underlie many of the symptoms in this disease. However, the mechanisms involved are not well understood. Although elucidating the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
